Chugai Pharmaceutical Co., Ltd. (CHGCF)
50.46
-0.68
(-1.33%)
USD |
OTCM |
May 21, 14:26
Chugai Pharmaceutical EPS Diluted (Quarterly) : 0.447 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| Daiichi Sankyo Co., Ltd. | 0.1472 |
| Eisai Co., Ltd. | -0.0184 |
| Santen Pharmaceutical Co., Ltd. | 0.3043 |
| Ono Pharmaceutical Co., Ltd. | 0.0036 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 735.63M |
| Revenue (Quarterly) | 2.051B |
| Total Expenses (Quarterly) | 1.315B |
| Enterprise Value | 78.93B |
| Gross Profit Margin (Quarterly) | 71.16% |
| Profit Margin (Quarterly) | 35.87% |
| Earnings Yield | 3.61% |
| Operating Earnings Yield | 5.20% |
| Normalized Earnings Yield | 3.827 |